These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 17845731

  • 1. Interrelated modulation of endothelial function in Behcet's disease by clinical activity and corticosteroid treatment.
    Protogerou AD, Sfikakis PP, Stamatelopoulos KS, Papamichael C, Aznaouridis K, Karatzis E, Papaioannou TG, Ikonomidis I, Kaklamanis P, Mavrikakis M, Lekakis J.
    Arthritis Res Ther; 2007; 9(5):R90. PubMed ID: 17845731
    [Abstract] [Full Text] [Related]

  • 2. Impaired endothelium-dependent flow-mediated dilation in Behçet's disease: more prominent endothelial dysfunction in patients with vascular involvement.
    Oflaz H, Mercanoglu F, Karaman O, Kamali S, Erer B, Genchellac H, Pamukcu B, Umman S, Inanc M, Gul A.
    Int J Clin Pract; 2005 Jul; 59(7):777-81. PubMed ID: 15963203
    [Abstract] [Full Text] [Related]

  • 3. Elevated oxidative stress markers and its relationship with endothelial dysfunction in Behçet disease.
    Acikgoz N, Ermiş N, Yağmur J, Cansel M, Karincaoğlu Y, Ataş H, Cuglan B, Barutcu I, Pekdemir H, Özdemir R.
    Angiology; 2011 May; 62(4):296-300. PubMed ID: 20947865
    [Abstract] [Full Text] [Related]

  • 4. The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance.
    Xiang GD, Sun HL, Zhao LS, Hou J, Yue L, Xu L.
    Clin Endocrinol (Oxf); 2008 May; 68(5):716-23. PubMed ID: 18070144
    [Abstract] [Full Text] [Related]

  • 5. Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke.
    Chan YH, Lau KK, Yiu KH, Li SW, Chan HT, Fong DY, Tam S, Lau CP, Tse HF.
    Eur Heart J; 2008 Nov; 29(22):2800-7. PubMed ID: 18812325
    [Abstract] [Full Text] [Related]

  • 6. Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function.
    Schiano V, Laurenzano E, Brevetti G, De Maio JI, Lanero S, Scopacasa F, Chiariello M.
    Clin Nutr; 2008 Apr; 27(2):241-7. PubMed ID: 18237823
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
    Probst K, Fijnheer R, Rothova A.
    Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149
    [Abstract] [Full Text] [Related]

  • 9. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B, Chong AY, Nuttall S, Lip GY.
    Thromb Res; 2008 May; 122(1):85-90. PubMed ID: 17996280
    [Abstract] [Full Text] [Related]

  • 10. Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis.
    Gonzalez-Juanatey C, Llorca J, Garcia-Porrua C, Sanchez-Andrade A, Martín J, Gonzalez-Gay MA.
    J Rheumatol; 2006 Jan; 33(1):74-8. PubMed ID: 16395753
    [Abstract] [Full Text] [Related]

  • 11. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
    Shechter M, Issachar A, Marai I, Koren-Morag N, Freinark D, Shahar Y, Shechter A, Feinberg MS.
    Int J Cardiol; 2009 May 01; 134(1):52-8. PubMed ID: 18479768
    [Abstract] [Full Text] [Related]

  • 12. Late-onset Behçet's disease does not correlate with indolent clinical course: report of seven Taiwanese patients.
    Tsai J, Chen GS, Lu YW, Wu CS, Lan CC.
    J Eur Acad Dermatol Venereol; 2008 May 01; 22(5):596-600. PubMed ID: 18266686
    [Abstract] [Full Text] [Related]

  • 13. Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity.
    Rudofsky G, Reismann P, Grafe IA, Konrade I, Djuric Z, Tafel J, Buchbinder S, Zorn M, Humpert PM, Hamann A, Morcos M, Nawroth PP, Bierhaus A.
    Horm Metab Res; 2007 Sep 01; 39(9):665-71. PubMed ID: 17846974
    [Abstract] [Full Text] [Related]

  • 14. Homocysteine: an activity marker in Behçet's disease?
    Sarican T, Ayabakan H, Turkmen S, Kalaslioglu V, Baran F, Yenice N.
    J Dermatol Sci; 2007 Feb 01; 45(2):121-6. PubMed ID: 17182219
    [Abstract] [Full Text] [Related]

  • 15. Effect of nebivolol on endothelial dysfunction in patients with Behçet's disease; a prospective single-arm controlled study.
    Akkaya H, Sahin O, Borlu M, Oğuzhan A, Karakaş MS.
    Anadolu Kardiyol Derg; 2013 Mar 01; 13(2):115-20. PubMed ID: 23228972
    [Abstract] [Full Text] [Related]

  • 16. Patients with Behcet's disease carry a higher risk for microvascular involvement in active disease period.
    Gullu H, Caliskan M, Erdogan D, Yilmaz S, Dursun R, Ciftci O, Topcu S, Yucel E, Muderrisoglu H.
    Ann Med; 2007 Mar 01; 39(2):154-9. PubMed ID: 17453678
    [Abstract] [Full Text] [Related]

  • 17. Plasma thrombomodulin levels in patients with Behçet's disease.
    Düzgün N, Ayaşlioğlu E, Tutkak H, Sahin M, Aydintuğ O, Olmez U.
    Rheumatol Int; 2003 May 01; 23(3):130-3. PubMed ID: 12739044
    [Abstract] [Full Text] [Related]

  • 18. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
    Kerekes G, Szekanecz Z, Dér H, Sándor Z, Lakos G, Muszbek L, Csipö I, Sipka S, Seres I, Paragh G, Kappelmayer J, Szomják E, Veres K, Szegedi G, Shoenfeld Y, Soltész P.
    J Rheumatol; 2008 Mar 01; 35(3):398-406. PubMed ID: 18203326
    [Abstract] [Full Text] [Related]

  • 19. [Comparative evaluation of the effectiveness of corticosteroids and cytostatics in treating retinal angiitis in Behcet's disease].
    Ermakova NA.
    Vestn Oftalmol; 2002 Mar 01; 118(5):32-5. PubMed ID: 12532744
    [Abstract] [Full Text] [Related]

  • 20. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women.
    Sherwood A, Bower JK, McFetridge-Durdle J, Blumenthal JA, Newby LK, Hinderliter AL.
    Arterioscler Thromb Vasc Biol; 2007 Aug 01; 27(8):1782-7. PubMed ID: 17541023
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.